NOT:ETR
Novartis AG
€137.84
arrow_upward
+0.58%(+0.80) 1D
Oct 22, 9:53:35 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOT...
Open
€137.90
High
€138.08
Low
€137.66
Mkt. cap
258.40B
Avg. vol.
5.38K
Volume
1.99K
52-wk high
€144.12
52-wk low
€104.52
No. of employees
75K
Open
€137.90
High
€138.08
Low
€137.66
Mkt. cap
258.40B
Avg. vol.
5.38K
Volume
1.99K
52-wk high
€144.12
52-wk low
€104.52
No. of employees
75K
News stories
From web sources and news partners
AD HOC NEWS
·
24 minutes ago
Novartis wins EU Cosentyx approval as Novartis stock trades at EUR 137.81
AD HOC NEWS
·
1 hour ago
Novartis stock pre-market at EUR 136.79: medicines company
Yahoo Finance
·
17 hours ago
Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)
AD HOC NEWS
·
18 hours ago
Novartis stock: UBS keeps Hold rating and CHF 116.00 target for Novartis stock
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com